Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
DNA Repair|April 27, 2018
Acetylation of oxidized base repair-initiating NEIL1 DNA glycosylase required for chromatin-bound repair complex formation in the human genome increases cellular resistance to oxidative stressShiladitya Sengupta, Chunying Yang, Muralidhar L Hegde, et al.
Nucleic Acids Research|October 30, 2016
Regulation of oxidized base damage repair by chromatin assembly factor 1 subunit AChunying Yang, Shiladitya Sengupta, Pavana M Hegde, et al.
Cancer Research|October 15, 2013
Sequential application of a cytotoxic nanoparticle and a PI3K inhibitor enhances antitumor efficacyAmbarish Pandey, Ashish Kulkarni, Bhaskar Roy, et al.
Molecular and Cellular Biology|December 21, 2016
Human Apurinic/Apyrimidinic Endonuclease (APE1) Is Acetylated at DNA Damage Sites in Chromatin, and Acetylation Modulates Its DNA Repair ActivityShrabasti Roychoudhury, Somsubhra Nath, Heyu Song, et al.
Nature Nanotechnology|November 19, 2021
Intercellular nanotubes mediate mitochondrial trafficking between cancer and immune cellsTanmoy Saha, Chinmayee Dash, Ruparoshni Jayabalan, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 12, 2020
Screening Cancer Immunotherapy: When Engineering Approaches Meet Artificial IntelligenceXingwu Zhou, Moyuan Qu, Peyton Tebon, et al.
ACS Nano|July 26, 2016
Algorithm for Designing Nanoscale Supramolecular Therapeutics with Increased Anticancer EfficacyAshish Kulkarni, Prithvi Pandey, Poornima Rao, et al.
Oncotarget|March 17, 2016
Regulation of limited N-terminal proteolysis of APE1 in tumor via acetylation and its role in cell proliferationKishor K Bhakat, Shiladitya Sengupta, Victor F Adeniyi, et al.
The Journal of Biological Chemistry|July 3, 2015
The C-terminal Domain (CTD) of Human DNA Glycosylase NEIL1 Is Required for Forming BERosome Repair Complex with DNA Replication Proteins at the Replicating Genome: DOMINANT NEGATIVE FUNCTION OF THE CTDPavana M Hegde, Arijit Dutta, Shiladitya Sengupta, et al.
Science Advances|June 14, 2024
Antibody nanoparticle conjugate-based targeted immunotherapy for non-small cell lung cancerTanmoy Saha, Michaela Fojtů, Astha Vinay Nagar, et al.
Pageof 12